Abstract
The present study leverages the comprehensive data from the National Health and Nutrition Examination Survey (NHANES) to examine the Influencing factors of sarcopenia (SA) and sarcopenic obesity (SO). The investigation is designed to a non-invasive, cost-effective, and convenient method that is applicable to the adult population, enabling the accurate and simultaneous detection of risks associated with SA and SO. Furthermore, this research will evaluate the critical values of effective anthropometric indicators, providing early warning for risk management in self-health care and offering valuable insights for subsequent research and clinical practice. The data pertaining to NHANES participants were meticulously selected from the databases of six cycles, spanning from 2001 to 2004 and 2011 to 2018. Utilizing the diagnostic criteria established by the American Foundation for the National Institutes of Health (FNIH), anthropometric measurement data were extracted to construct composite indices. These indices were then cross-referenced with diagnostic assessments from dual-energy X-ray absorptiometry and bioelectrical impedance analysis to examine the correlations between various metrics and the incidence of diseases. R software (version 4.3.3) was used for analysis, and the primary analytical methods employed included logistic regression, restricted cubic splines (RCS), and the Receiver Operating Characteristic (ROC) curve analysis (AUC). Sarcopenia and sarcopenic obesity are commonly observed in individuals within the middle-aged and elderly demographics. The prevalence of these conditions is higher among middle-aged men of a given age when contrasted with women at the age of 40. All anthropometric indexes demonstrated a positive correlation with the onset of SA and SO, with the association with waist-to-height ratio (WHtR) showcasing a heightened strength subsequent to the adjustment for all covariates. The predictive models of all ROC curves performed commendably, particularly with the body roundness index and WHtR forecasting models exhibiting superior performance, the area under the AUC curve is 0.87 (95 CI% 0.85, 0.88) and 0.86 (95 CI% 0.85, 0.88), respectively. The RCS curve delineated a distinctive J-shaped distribution for each physical index in concurrence with SA and SO, signifying an optimal value at which the incidence of these conditions is minimal; conversely, deviations from this optimal value entailed an escalated risk of disease. Diverse anthropometric index metrics bear a strong correlation with adult onset of sarcopenia and sarcopenic obesity, each displaying commendable predictive capability. Notably, the body roundness index and waist-to-height ratio may harbor heightened potential as indicative anthropometric indexes. Furthermore, the dose-effect relationship analysis inferred that the lowest disease risk is manifested among individuals with specific index profiles, thereby advocating for autonomous health monitoring to promote physical activity and bolster nutrient intake, thus mitigating the risk of sarcopenia and sarcopenic obesity.
Similar content being viewed by others
Introduction
Sarcopenia (SA), a multifaceted syndrome, increases the risk of falls, fractures, and impaired daily activities1,2. It is further correlated with elevated overall mortality rates, an increased susceptibility to depression, and a spectrum of metabolic disorders3, exerting a profound impact on the individual, community, and economy4. The concurrent occurrence of excessive adiposity and diminished muscle mass is designated as sarcopenic obesity (SO)5, a complication emanating from the amalgamation of sarcopenia and obesity6. Sarcopenic obesity is closely associated with frailty, compromised cardiovascular metabolic function, physical disability, and mortality7.
Presently, conventional modalities for diagnosing skeletal muscle wasting encompass magnetic resonance imaging (MRI) and computed tomography (CT), methodologies that provide precise direct observations, necessitate the utilization of costly equipment and incur significant evaluation costs. Bioelectrical impedance analysis (BIA) stands out as a prevalent evaluation technique8,9, capable of delivering relatively accurate results with relative ease. However, it remains susceptible to a variety of influences, including electrode placement, variations in testing positions, and changes in body fluid composition10. Additionally, discrepancies in outcomes may arise due to variations among different device models11. Dual-energy X-ray absorptiometry (DEXA) is extensively acknowledged as the prevalent method for the assessment of SA and SO, lauded for its cost-effectiveness and considerable precision12. Nevertheless, the necessity for a certain level of equipment proficiency poses a limitation on its application, thereby restricting the capacity for self-monitoring and the evaluation of daily living activities within populations at elevated risk. Beyond the application of equipment, the diagnostic process for sarcopenia frequently involves the use of various questionnaires, including but not limited to SARC-F, SARC-CalF, MSRA-5, and MSRA-7. However, the existing literature displays a notable lack of consensus regarding the validity of these questionnaires. Furthermore, the process of questionnaire completion may be prone to biases introduced by subjective factors13,14.
In light of the widening chasm in health disparities, the restricted access to medical care, and the unrelenting escalation of healthcare costs15, the practice of self-health management has emerged as a promising intervention strategy16. This entails individuals acquiring the competencies necessary for monitoring their own health status and utilizing behavioral goals as motivational drivers17. A robust correlation exists between anthropometric indices and behaviors pertinent to self-health management18, the outcomes of measurements contribute significantly to the facilitation of self-management practices19. Anthropometric indices are synthesized into specific metrics through formulaic calculations, providing a delineation of an individualâs relative physical health status. The principal advantage of this method lies in its measurement simplicity20, in addition to the fact that numerous studies affirming the value of anthropometric indices in forecasting conditions such as obesity, cardiovascular disease, and nephrolithiasis21,22,23,24, as well as in discerning the association between these indices and overall mortality rates25.
The calf circumference (CC) metric is widely utilized as a convenient and relatively precise indicator in the assessment of elderly patientsâ sarcopenia26. However, due to the potential for obesity to distort limb measurements, the accurate application of the CC index necessitates adjustment in relation to Body Mass Index (BMI)27. This adjustment may diminish the predictive value in patients with sarcopenic obesity, potentially leading to misdiagnoses that could exacerbate the progression of sarcopenic obesity and precipitate the onset of comprehensive sarcopenia28. Commonly used anthropometric indicators, such as body weight and BMI, are relatively straightforward to calculate but are limited in their ability to detect overweight populations29,30,31. Utilizing these as the sole criteria for assessing obesity may lead to misclassification of individuals with occult obesity or those with resilient physiologies32, thereby underestimating the health risks associated with visceral adiposity33,34. A considerable proportion of the elderly exhibit a normal BMI, yet may be afflicted by varying degrees of sarcopenic obesity prior to the manifestation of pronounced muscle atrophy35. Consequently, it is essential to appraise a range of anthropometric indicators and to elucidate their correlations with disease risk36. Research indicates that indices such as the Body Roundness Index (BRI), the z-score of the log-transformed A Body Shape Index (LBSIZ), the A Body Shape Index (ABSI), and the Waist-to-Height Ratio (WHtR) are instrumental in the detection of SA or SO37,38,39,40. Despite evidence linking anthropometric indicators to specific metabolic ailments41, the relationship between these indicators and sarcopenia, as well as sarcopenic obesity, necessitates further investigation. Moreover, a consensus on the diagnostic criteria for the condition remains elusive42. A comprehensive comparison across a substantial dataset should be conducted to identify the optimal solution.
The present study leverages the comprehensive data from the National Health and Nutrition Examination Survey (NHANES) to examine the Influencing factors of SA and SO. The investigation is designed to a non-invasive, cost-effective, and convenient method that is applicable to the adult population, enabling the accurate and simultaneous detection of risks associated with SA and SO. Furthermore, this research will evaluate the critical values of effective anthropometric indicators, providing early warning for risk management in self-health care and offering valuable insights for subsequent research and clinical practice.
Methods
Study participants
This study is a cross-sectional study, and the data is derived from the US NHANES database (https://www.cdc.gov/nchs/nhanes/index.htm). The data in this database comes from a nationwide health survey conducted annually, using a complex, multi-stage probability sampling method that can represent the health and nutritional status of the population43. All participants signed written informed consent forms.
Age-related aging is often considered a cause of sarcopenia (SA) and osteopenia (SO). Studies have shown that factors such as exercise, chronic inflammation, and nutritional status also affect the onset of SA and SO44,45. Due to the limitations of the measurement content of the database in different years, this study extracted DEXA measurement data and relevant covariates from the NHANES database from 2011 to 2018 as the main research objects, and used relevant data measured by BIA in the 2001â2004 database for index verification. After screening the data from 2011 to 2018, excluding individuals under 20 years of age and those with missing data, this study finally included 8159 participants (Fig. 1).
Measurements
Disease threshold measurement
The data utilized in this study are derived from the National Health and Nutrition Examination Survey in the United States. Consequently, the racial characteristics are assessed in accordance with the standards established by the American Foundation for the National Institutes of Health (FNIH)46. The diagnosis of sarcopenia is established when the total skeletal muscle mass/body mass index (BMI) measured by dual-energy X-ray falls below 0.789Â kg/BMI in men and below 0.512Â kg/BMI in women. If the criteria for sarcopenia are met and BMI is equal to or exceeds 30, it is diagnosed as sarcopenic obesity5.
Furthermore, bioelectrical impedance analysis (BIA) can be utilized to estimate sarcopenia47. In line with the equipment requisites of the 2001â2004 NHANES survey, regression equations are employed to calculate skeletal muscle mass (SM) using resistance values48:
Subsequently, the estimated SM is inputted into the equation to compute the skeletal muscle mass index (SMI), with the high-risk threshold for sarcopenia identified as 8.50Â kg/m2 for men and 5.75Â kg/m2 for women49.
Anthropometric index measurement
The requisite data for computing diverse anthropometric parameters encompass measurements such as waist circumference, height, and weight, delineated in a multitude of units. The computational algorithms and units pertinent to assorted physical indices are delineated in Table 1.
Other indicatorsâ measurement
The nutrient intake data were collected via in-person interviews. All dietary interviewers underwent a rigorous week-long training program and completed practical exercises prior to conducting independent interviews. The specific procedures followed the âNHANES Dietary Recall Interview Measurement Guidelinesâ. Study participants were interviewed on consecutive days, and the data used in the study represent their daily average energy and protein intake.
Information on physical inactivity and sedentary behavior was obtained through interviews and questionnaires based on the World Health Organizationâs Global Physical Activity Questionnaire (GPAQ). Interviewers utilized computer-assisted personal interview systems to survey participants at their homes, inquiring about their typical daily sedentary time. There is a linear correlation between sitting time and the risk of metabolic syndrome51, according to the SIT-ACT risk matrix52, sedentary behavior data were extracted and standardized into time units (hours), and then categorized into four levels: less than 4Â h, 4â6Â h, 6â8Â h, and more than 8Â h.
Demographic variables, including age, sex, race, education level, and poverty level, were collected by trained interviewers at participantsâ residences using computer-assisted personal interview systems. Relevant demographic data were extracted for the study, and a sophisticated weighted process was applied to the overall data using sample weight.
Statistical analysis
In the investigation, R software (version 4.3.3) was employed for statistical analysis, wherein all analyses were appropriately weighted using the survey package. Categorical variables were presented as frequencies in percentages, while continuous variables were represented as means along with their 95% confidence intervals. To examine the association between different body mass index categories and adult sarcopenia, as well as sarcopenic obesity, several logistic regression models were established, including Model 1, Model 2, and Model 3, which were adjusted for various covariates.
Furthermore, the rms package within the R software facilitated the execution of restricted cubic spline (RCS) analysis, thereby elucidating the dose-response relationship between body measurement indicators and the risk of adult sarcopenia and sarcopenic obesity. The analysis involved comparison of subgroups by sex, with the number of nodes being set to 4 based on percentiles (P5, P25, P75, P95)53. Post stepwise regression selection, models predicting sarcopenia and sarcopenic obesity were formulated utilizing diverse body measurement indicators. Subsequently, the pROC and ggplot2 packages were utilized to craft receiver operating characteristic (ROC) curves.
Moreover, the data underwent division into a training set and a validation set at an 8:2 ratio to verify the stability of the model. Lastly, the data measured by bioelectrical impedance in the NHANES database from 2001 to 2004 was re-fitted to authenticate the predictive findings.
Results
Baseline data distribution
Population Representation and Demographics This investigation encompassed a cohort of 8159 individuals and, through utilizing a meticulously calculated complex weighted population estimate, is anticipated to mirror the characteristics of 213,963,585 U.S. residents aged 20 years and above. The mean age of the aforementioned 8159 participants was recorded as (39.40â±â11.53) years. The sex distribution of the participants is equitable, with individuals of non-Hispanic white descent constituting the preponderance (63%) of the study population. Furthermore, a majority of participants boast a high school education or above (67%), while the prevalence of sedentary behavior exceeding 8 h is notably pervasive (41%). Examination focusing on groups afflicted by sarcopenia and sarcopenic obesity unveiled a predilection for these maladies among older age cohorts, with a slightly elevated prevalence of these conditions witnessed among male participants in comparison to their female counterparts, as explicated in Table 2.
Associations and Correlations Employing normative adults and individuals afflicted by sarcopenia as comparative reference points, logistic regression analysis accounting for adjusted weights revealed a significant correlation between advanced age, race, socioeconomic status, educational attainment, hyperglycemia, physical inactivity, caloric intake, and protein consumption with the occurrence of sarcopenia and sarcopenic obesity, all attaining statistical significance (Pâ<â0.05). Conversely, no statistically significant correlations were discerned in relation to sex, hypertension, hypercholesterolemia, and prolonged sedentary behavior (Pâ>â0.05) (Table 2).
Correlation analysis of various anthropometric indices
Controlled for various covariates, three regression models were formulated, and collinearity diagnostics revealed the absence of multicollinearity issues (VIFâ<â5). The outcomes of the univariate logistic regression model (Model 1) exhibited a positive correlation between all metrics and the overall incidence rates of SA and SO, and were of statistical significance (Pâ<â0.05). Notably, the association between body mass index and waist-to-height ratio displayed heightened strength. Upon adjusting for demographic variables (Model 2), all metrics sustained their positive correlation with the incidence rates of SA and SO, retaining statistical significance (Pâ<â0.05). The association strength of the waist-to-height ratio was notably robust. Comparable findings were derived after controlling for all covariates (Table 3).
Receiver-operating characteristic (ROC) curve analysis and optimum thresholds for anthropometric indices
The prognostic models for diverse anthropometric indicators demonstrated commendable performance (AUCâ>â0.7), with each model showcasing discernible predictive capability. Furthermore, the AUC value in the validation cohort corresponded with the training cohort, affirming the sustained predictive efficacy of the models in the validation group. In the SA training samples, the BRI indicator yielded the most robust predictive effect for SA (AUCâ=â0.867), closely pursued by WHtR (AUCâ=â0.862). Conversely, in the SO training samples, WHtR emerged as the most potent predictor for SO (AUCâ=â0.857), followed by BRI (AUCâ=â0.855). Noteworthy is the comparatively suboptimal predictive efficacy of the ABSI and LBSIZ models for SA and SO (Fig. 2).
The evaluation scores for each indicator were notably elevated, with the BRI metric exhibiting the highest Youden index, implicating its relatively heightened discriminatory ability for SA and SO. The sensitivity and specificity of the varied anthropometric indicators in predicting the onset of SA and SO are featured in Table 4.
Curves 1 to 5 correspond to the following anthropometric indices: ABSI, LBSIZ, BRI, BMI, WHtR.
Anthropometric indicators were used to predict SA and SO data derived from BIA measurements, and the results showed that the effect of each indicator model was good (AUCâ>â0.8) (Fig. 3).
ROC curve of anthropometric indicators predicting BIA data. (A) Presents the ROC curve for the prediction of SA occurrence in the BIA data based on human anthropometric measurements; (B) exhibits the ROC curve for the prediction of SO occurrence in the BIA data. Curves 1 to 5 correspond to the following anthropometric indices: ABSI, LBSIZ, BRI, BMI, WHtR.
Dose-response relationship of anthropometric indicators
Restrictive cubic spline visualization reveals a notable phenomenon wherein each anthropometric index exhibits a J-shaped correlation with the propensity for obstructive sleep apnea and snoring incidences, with a statistical significance of Pâ<â0.0001 (Fig. 4).
For instance, taking the body roundness index (BRI) as a case in point, the risk of SA is minimized at a BRI value of 3.6, while the risk of SO reaches its nadir at a BRI of 3.7. Notably, any deviation from these optimal BRI values will result in an escalated risk of SA and SO occurrences.
Dose-effect relationship between anthropometric indexes and SA and SO occurrence. (A,C,E,G,I) are the dose-effect relationship between BRI, ABSI, WHtR, LBSIZ, BMI and SA occurrence, respectively. (B,D,F,H,J) are the dose-effect relationship between BRI, ABSI, WHtR, LBSIZ, BMI and SO occurrence, respectively.
Within the cohort of individuals aged 40, a stratified analysis by sex among the middle-income group unveils a sexual disparity in the incidence rates of SA and SO, with a higher prevalence observed among males compared to females. However, with the advancement of age, the prevalence rates of SA and SO among females increased at a faster pace than those of males. Notably, at a BRI value of 3.6, the risk of SA is mitigated for both sexes, whereas for females, a BRI range between 2.3 and 4.4 signifies a risk of SA lower than unity. Similarly, at a BRI value of 3.7, the risk of SO is minimized for both sexes, while for females, a BRI range between 2.3 and 5.0 corresponds to an SO risk below one (Fig. 5).
Dose-effect relationship between SA and SO risk by sex 1 for male and 2 for female. (A) Is the dose-effect relationship of SA risk of different BRI index, (B) is the dose-effect relationship of SO risk of different BRI index, (C) is the dose-effect relationship of SA risk of different age, and (D) is the dose-effect relationship of SO risk of different age.
Discussion
This investigation reveals that hypertension and high cholesterol levels are not significantly associated with SA and SO, statistically speaking. Contrary to research suggesting a linkage between hypertension, high cholesterol, and the incidence of SA and SO54,55,56,57, the findings of the present study lends support to an opposing hypothesis58. The discrepancy in outcomes may be attributed to variations in the study cohort and the metrics employed for assessment, which could account for the observed inconsistency in results58.There is a positive associations between all anthropometric measurements and the incidence of SA and SO. After controlling for all covariates, the correlation between WHtR and SA, SO was found to be stronger, indicating a potential association between elevated WHtR and increased risk of metabolic diseases59. The ROC curve was employed in the construction of the prediction model, demonstrating excellent performance across all models. Notably, the Body Roundness Index (BRI) and the WHtR, metrics utilized to quantify central adiposity60,61, have demonstrated a high degree of validity in these analyses.
Patients afflicted with SA and SO frequently present with abdominal obesity and visceral fat accumulation34,62, Differential distribution of body fat exerts a significant impact on metabolic function63. An excessive accumulation of adipose tissue disrupts homeostasis and triggers a cascade of inflammatory responses. Moreover, the interplay between adipokines and myokines, along with a dysregulated immune-inflammatory response, interferes with the regenerative processes of skeletal muscle, potentially leading to comprehensive sarcopenia and sarcopenic obesity64,65. Diverging from the outcomes of prior research40, the predictive efficacy of the ABSI and LBSIZ models appears to be relatively modest. The potential explanation for this discrepancy could be that SA and SO are chronic conditions associated with aging, and the ABSI and LBSIZ may not be robust predictors for chronic illnesses66, these indices may serve a supplementary role in the initial evaluation of human tissue distribution24.
The RCS curve illustrates that each anthropometric index displays a J-shaped curve with respect to sarcopenia (SA) and osteopenia (SO), suggesting the presence of an optimal threshold for the anthropometric index where the prevalence of SA and SO is minimized. Any deviation from this threshold will augmented the susceptibility to disease development. The present investigation indicate that among the 40-year-old demographic, males exhibit a higher incidence of disease. Beginning at the age of 30, there is an annual decrease of approximately 1% in testosterone levels among males67. The elevation of visceral adiposity resultant from this decline in testosterone can elicit a catabolic influence on muscle tissue through the action of pro-inflammatory cytokines68. In females, oestrogen is instrumental in promoting growth and maintaining muscle mass in females, with estradiol specifically mitigating inflammatory stress-related damage to skeletal muscle69,70. Nonetheless, it is pertinent to highlight that the decline in estrogen levels post-menopause is often associated with a propensity for increased subcutaneous fat deposition. This shift may conducive to enhanced adiposity in postmenopausal women, thereby potentially predisposing them to the onset of SA and SO71,72. Individuals in middle age and older adulthood, irrespective of biological sex, should prioritize the regular assessment of their skeletal muscle health, assessing health risks, ensuring adequate intake of protein and energy in their daily lives, and enhancing physical activity as well as adhering to a regimen of regular exercise.
This investigation proposes that when assessing primary medical care and physical fitness, the consideration of BMI alone is insufficient. It is imperative to also take into account the results of body measurement indexes such as BRI and WHtR, as their relevance to the risk of SA and SO is more pronounced. The practical utility of these indices is underscored by their facilitation in measurement, capacity for direct computation, and high level of precision.
Despite the studyâs strength in its substantial and representative sample size, several limitations must be acknowledged. Primarily, the cross-sectional nature of this research precludes a thorough investigation into causal relationships. Secondly, although the analysis has been adjusted for a selection of potential confounding variables, the possibility of residual confounding remains. Furthermore, the study fails to address the mechanistic association between muscle loss syndrome and osteoporosis73,74, a link compounded by hormone levels impacting not only muscle tissue but also closely intertwining with mineral metabolism in bones75. However, this study neglects to delve into the complications of SA and SO, such as osteoporosis, due to the presence of confounding factors. In addition, owing to the lack of data pertaining to calf circumference (CC) and mid-upper arm circumference (AC) within the database, this investigation was precluded from conducting a comparative analysis of the predictive efficacy of the anthropometric indices under consideration with those methods. Lastly, given that the studyâs population primarily comprises Americans, further research is requisite to explore the association between body measurement indexes and SA and SO in Asian populations.
Conclusions
A variety of anthropometric measurements demonstrate significant associations with adult sarcopenia and sarcopenic obesity, representing valuable predictive factors. Notably, the body roundness index (BRI) and the waist-to-height ratio (WHtR) emerge as particularly promising anthropometric indicators. Furthermore, a dose-response analysis reveals the optimal thresholds for these measurements, corresponding to the lowest risk of developing sarcopenia and sarcopenic obesity. Consequently, it is prudent for individuals reaching middle age and beyond to endeavor towards vigilant surveillance of their muscular health and concomitant health risks. Embracing a regimen that ensures adequate daily protein and energy intake, in conjunction with a commitment to regular physical exercise, stands pivotal in the endeavor to safeguard overall well-being.
Data availability
All data are available at the National Health and Nutrition Examination Survey (https://www.cdc.gov/nchs/nhanes/index.htm).In addition, the data files used have been provided in the ârelated filesâ.
References
Schaap, L. A., Van Schoor, N. M., Lips, P. & Visser, M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study Amsterdam. J. Gerontol. A. 73, 1199â1204 (2018).
Malmstrom, T. K., Miller, D. K., Simonsick, E. M., Ferrucci, L. & Morley, J. E. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J. Cachexia Sarcopenia Muscle 7, 28â36 (2016).
Xia, L. et al. Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies. Cancer Med. 9, 7964â7978 (2020).
Mijnarends, D. M. et al. Muscle, health and costs: a glance at their relationship. J. Nutr. Health Aging 22, 766â773 (2018).
Donini, L. M. et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes. Facts 15, 321â335 (2022).
Choi, K. M. Sarcopenia and sarcopenic obesity. Korean J. Intern. Med. 31, 1054â1060 (2016).
Colleluori, G. & Villareal, D. T. Aging, obesity, Sarcopenia and the effect of diet and exercise intervention. Exp. Gerontol. 155, 111561 (2021).
Petermann-Rocha, F. et al. Global prevalence of Sarcopenia and severe Sarcopenia: a systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle 13, 86â99 (2022).
Marini, E., Sulis, S., Vorobelâová, L. & Stagi, S. Specific bioelectrical vectors pattern in individuals with sarcopenic obesity. Clin. Nutr. 43, 620â628 (2024).
Aleixo, G. F. P. et al. Bioelectrical impedance analysis for the assessment of Sarcopenia in patients with cancer: a systematic review. Oncologist 25, 170â182 (2020).
Gonzalez, M. C., Barbosa-Silva, T. G. & Heymsfield, S. B. Bioelectrical impedance analysis in the assessment of Sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 21, 366â374 (2018).
Albano, D., Messina, C., Vitale, J. & Sconfienza, L. M. Imaging of Sarcopenia: old evidence and new insights. Eur. Radiol. 30, 2199â2208 (2020).
Li, R. et al. Screening for Sarcopenia with a self-reported cartoon questionnaire: combining SARC-F with finger-ring test. J. Nutr. Health Aging 24, 1100â1106 (2020).
Lu, J. L. et al. Comparison of five sarcopenia screening tools in preoperative patients with gastric cancer using the diagnostic criteria of the European Working Group on Sarcopenia in Older People 2. Nutrition 95, 111553 (2022).
Cannard, C., Brandmeyer, T., Wahbeh, H. & Delorme, A. Self-health monitoring and wearable neurotechnologies. Handb. Clin. Neurol. 168, 207â232 (2020).
Hadjiconstantinou, M. et al. Using intervention mapping to develop a digital self-management program for people with type 2 diabetes: Tutorial on MyDESMOND. J. Med. Internet Res. 22, e17316 (2020).
Bandura, A. Health promotion by social cognitive means. Health Educ. Behav. 31, 143â164 (2004).
Sobhani, Z. et al. Self-management behaviors and anthropometric indices after Roux-en-Y gastric bypass. World J. Surg. 45, 1812â1817 (2021).
Hu, J., Basit, T., Nelson, A. & Bartlett, A. Changes in exercise capacity and anthropometric measures after work it out-a holistic chronic disease self-management program for urban aboriginal and Torres Strait Islander people. Public Health 174, 49â55 (2019).
Yang, J. et al. Using different anthropometric indices to assess prediction ability of type 2 diabetes in elderly population: a 5 year prospective study. BMC Geriatr. 18, 218 (2018).
Wei, L. & Xue, W. Comparisons of visceral adiposity index, body shape index, body mass index and waist circumference and their associations with diabetes mellitus in adults. Nutrients 11, 1580 (2019).
Tang, L. & Zeng, L. Comparative efficacy of anthropometric indices in predicting 10-year ASCVD risk: insights from NHANES data. Front. Cardiovasc. Med. 11, 1341476 (2024).
Hu, X. et al. Association of novel anthropometric indices with prevalence of kidney stone disease: a population-based cross-sectional study. Eur. J. Med. Res. 29, 204 (2024).
Qiao, Y. S. et al. Association of Sarcopenia and a body shape index with overall and cause-specific mortality. Front. Endocrinol. 13, 839074 (2022).
Lee, H. et al. Association between body shape index and risk of mortality in the United States. Sci. Rep. 12, 11254 (2022).
Lian, R. et al. Validated tools for screening Sarcopenia: a scoping review. J. Am. Med. Dir. Assoc. 24, 1645â1654 (2023).
Gonzalez, M. C., Mehrnezhad, A., Razaviarab, N., Barbosa-Silva, T. G. & Heymsfield, S. B. Calf circumference: cutoff values from the NHANES 1999â2006. Am. J. Clin. Nutr. 113, 1679â1687 (2021).
Ghaben, A. L. & Scherer, P. E. Adipogenesis and metabolic health. Nat. Rev. Mol. Cell. Biol. 20, 242â258 (2019).
Souza, L. F. D. et al. Are sociodemographic and anthropometric variables effective in screening probable and confirmed Sarcopenia in community-dwelling older adults? A cross-sectional study. Sao Paulo Med. J. 141, e2022141 (2023).
Pinheiro, P. A. et al. Anthropometric indicators as screening tools for Sarcopenia in older adult women. Enferm ClÃn. 30, 269â274 (2020).
Esteves, C. L. et al. Anthropometric indicators as a discriminator of Sarcopenia in community-dwelling older adults of the Amazon region: a cross-sectional study. BMC Geriatr. 20, 518 (2020).
Lam, B. C. C., Koh, G. C. H., Chen, C., Wong, M. T. K. & Fallows, S. J. Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS ONE 10, e0122985 (2015).
Ardesch, F. H. et al. The obesity paradox in lung cancer: associations with body size versus body shape. Front. Oncol. 10, 591110 (2020).
Gažarová, M., Bihari, M., Lorková, M., Lenártová, P. & Habánová, M. The use of different anthropometric indices to assess the body composition of young women in relation to the incidence of obesity, Sarcopenia and the premature mortality risk. Int. J. Environ. Res. Public. Health 19, 12449 (2022).
Li, C. et al. Pathogenesis of Sarcopenia and the relationship with fat mass: descriptive review. J. Cachexia Sarcopenia Muscle 13, 781â794 (2022).
DeLacey, S. & Josefson, J. L. A mini-review of pediatric anthropometrics as predictors of future insulin resistance. Front. Endocrinol. 13, 826430 (2022).
Zhang, X. et al. Associations of body-roundness index and sarcopenia with cardiovascular disease among middle-aged and older adults: findings from CHARLS. J. Nutr. Health Aging 27, 953â959 (2023).
Moon, S., Kim, Y. J., Yu, J. M., Kang, J. G. & Chung, H. S. Z-score of the log-transformed a body shape index predicts low muscle mass in population with abdominal obesity: the US and Korea National Health and Nutrition Examination Survey. PLoS ONE 15, e0242557 (2020).
Biolo, G. et al. Inverse relationship between âa body shape indexâ (ABSI) and fat-free mass in women and men: insights into mechanisms of sarcopenic obesity. Clin. Nutr. 34, 323â327 (2015).
Chung, W. et al. Utility of the Z-score of log-transformed a body shape index (LBSIZ) in the assessment for sarcopenic obesity and cardiovascular disease risk in the United States. Sci. Rep. 9, 9292 (2019).
Jayedi, A. et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ 376, e067516 (2022).
Barazzoni, R. et al. Sarcopenic obesity: time to meet the challenge. Clin. Nutr. 37, 1787â1793 (2018).
Ahluwalia, N., Dwyer, J., Terry, A., Moshfegh, A. & Johnson, C. Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv. Nutr. 7, 121â134 (2016).
Wang, M. et al. Diabetes and sarcopenic obesity: Pathogenesis, diagnosis, and treatments. Front. Endocrinol. 11, 568 (2020).
Robinson, S. M. et al. Does nutrition play a role in the prevention and management of Sarcopenia? Clin. Nutr. 37, 1121â1132 (2018).
Studenski, S. A. et al. The FNIH Sarcopenia project: Rationale, study description, conference recommendations, and final estimates. J. Gerontol. A 69, 547â558 (2014).
Cheng, K. Y. et al. Diagnosis of Sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual-energy X-ray absorptiometry. J. Cachexia Sarcopenia Muscle 12, 2163â2173 (2021).
Janssen, I., Heymsfield, S. B., Baumgartner, R. N. & Ross, R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J. Appl. Physiol. 89, 465â471 (2000).
Janssen, I. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am. J. Epidemiol. 159, 413â421 (2004).
Chung, W., Park, C. G. & Ryu, O. H. Association of a new measure of obesity with hypertension and health-related quality of life. PLoS ONE 11, e0155399 (2016).
Gennuso, K. P., Gangnon, R. E., Thraen-Borowski, K. M. & Colbert, L. H. Dose-response relationships between sedentary behaviour and the metabolic syndrome and its components. Diabetologia 58, 485â492 (2015).
Dunstan, D. W., Dogra, S., Carter, S. E. & Owen, N. Sit less and move more for cardiovascular health: emerging insights and opportunities. Nat. Rev. Cardiol. 18, 637â648 (2021).
Desquilbet, L. & Mariotti, F. Dose-response analyses using restricted cubic spline functions in public health research. Stat. Med. 29, 1037â1057 (2010).
Jurdana, M. & Žiberna, L. Sarcopenic obesity and hypertension in elderly patients: a narrative review of pathophysiology and management strategies. Ann. Ist Super Sanita 59, 231â239 (2023).
Xing, E. & Wan, C. Prevalence of and factors associated with sarcopenia among elderly individuals with hypertension. J. Int. Med. Res. 50, 030006052211104 (2022).
Hua, N. et al. High-density lipoprotein cholesterol level and risk of muscle strength decline and sarcopenia in older adults. Clin. Nutr. 43, 2289â2295 (2024).
Jiang, Y. et al. The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study. Sci. Rep. 13, 17538 (2023).
Pasdar, Y. et al. Association of obesity, Sarcopenia, and sarcopenic obesity with hypertension in adults: a cross-sectional study from Ravansar, Iran during 2014â2017. Front. Public Health 9, 705055 (2022).
Yang, B. et al. Trends in elevated waist-to-height ratio and waist circumference in US adults and their associations with cardiometabolic diseases and cancer, 1999â2018. Front. Nutr. 10, 1124468 (2023).
Mao, T., He, Q., Yang, J., Jia, L. & Xu, G. Relationship between gout, hyperuricemia, and obesity-does central obesity play a significant role?âA study based on the NHANES database. Diabetol. Metab. Syndr. 16, 24 (2024).
Gažarová, M., Bihari, M. & Å oltÃs, J. Fat and fat-free mass as important determinants of body composition assessment in relation to sarcopenic obesity. Rocz. Panstw Zakl. Hig. 74, 59â69 (2023).
Kim, H. K. et al. Association of visceral fat obesity, Sarcopenia, and myosteatosis with non-alcoholic fatty liver disease without obesity. Clin. Mol. Hepatol. 29, 987â1001 (2023).
Palmer, A. K. & Jensen, M. D. Metabolic changes in aging humans: current evidence and therapeutic strategies. J. Clin. Investig. 132, e158451 (2022).
Park, M. J. & Choi, K. M. Interplay of skeletal muscle and adipose tissue: sarcopenic obesity. Metabolism 144, 155577 (2023).
Polyzos, S. A., Vachliotis, I. D. & Mantzoros, C. S. Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease. Metabolis 147, 155676 (2023).
Ji, M., Zhang, S. & An, R. Effectiveness of a body shape index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis. Obes. Rev. 19, 737â759 (2018).
Roh, E. & Choi, K. M. Health consequences of sarcopenic obesity: a narrative review. Front. Endocrinol. (Lausanne) 11, 332 (2020).
Tian, X., Lou, S. & Shi, R. From mitochondria to Sarcopenia: role of 17β-estradiol and testosterone. Front. Endocrinol. 14, 1156583 (2023).
Carson, J. A. & Manolagas, S. C. Effects of sex steroids on bones and muscles: similarities, parallels, and putative interactions in health and disease. Bone 80, 67â78 (2015).
Geraci, A. et al. Sarcopenia and menopause: the role of estradiol. Front. Endocrinol. 12, 682012 (2021).
Lu, L. & Tian, L. Postmenopausal osteoporosis coexisting with Sarcopenia: the role and mechanisms of estrogen. J. Endocrinol. 259, e230116 (2023).
Divaris, E., Anagnostis, P., Gkekas, N. K., Kouidi, E. & Goulis, D. G. Early menopause and premature ovarian insufficiency may increase the risk of Sarcopenia: a systematic review and meta-analysis. Maturitas 175, 107782 (2023).
Reginster, J. Y., Beaudart, C., Buckinx, F. & Bruyère, O. Osteoporosis and sarcopenia: two diseases or one? Curr. Opin. Clin. Nutr. Metab. Care 19, 31â36 (2016).
Spanoudaki, M. et al. Sarcopenia and sarcopenic obesity and osteoarthritis: a discussion among muscles, fat, bones, and aging. Life (Basel) 13, 1242 (2023).
Almeida, M. et al. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol. Rev. 97, 135â187 (2017).
Acknowledgements
We would like to express our gratitude to The National Health and Nutrition Examination Survey for the comprehensive data provided, and express our sincere gratitude to the teachers and fellow students who participated in this study.
Author information
Authors and Affiliations
Contributions
W. X. is responsible for writing the topic of the paper, C. Z. and Z. Y. provide technical help on the paper, and Professor Ren Hong provides guidance and assistance in all aspects.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
This study was approved by the Ethics Committee of Beijing Sport University, all methods are carried out in accordance with the relevant guidelines and regulations.
Informed consent
This paper is based on an open database analysis of existing data, and all participants had signed informed consent forms at the time of data collection.
Additional information
Publisherâs note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the articleâs Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the articleâs Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Wu, X., Chen, Z., Zhao, Y. et al. Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity. Sci Rep 14, 31776 (2024). https://doi.org/10.1038/s41598-024-82751-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-82751-7